159 filings
8-K
OSCI
Oscient Pharmaceuticals Corp
13 Jul 09
Bankruptcy or Receivership
12:00am
8-K
OSCI
Oscient Pharmaceuticals Corp
22 Jun 09
Other Events
12:00am
8-K
OSCI
Oscient Pharmaceuticals Corp
16 Jun 09
Cost Associated with Exit or Disposal Activities
12:00am
8-K
OSCI
Oscient Pharmaceuticals Corp
29 May 09
Other Events
12:00am
8-K
OSCI
Oscient Pharmaceuticals Corp
22 May 09
Oscient Pharmaceuticals Receives NASDAQ Letter Regarding
12:00am
8-K
tt2lx3i
19 May 09
Other Events
12:00am
8-K
b65m0t8lhe6
15 May 09
Other Events
12:00am
8-K
8s9uy4 foc0j2ed
1 May 09
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
12:00am
8-K
oixvvbcf2aeo
29 Apr 09
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
12:00am
8-K
pobaa kzpn3v
27 Mar 09
Departure of Directors or Certain Officers
12:00am
8-K
r708peor un
25 Mar 09
Oscient Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Financial Results
12:00am
8-K
y2urzldqbdiauc
23 Mar 09
Departure of Directors or Certain Officers
12:00am
8-K
4y4lit7j4a4cgh
13 Feb 09
Cost Associated with Exit or Disposal Activities
12:00am
8-K
938ew
3 Feb 09
Entry into a Material Definitive Agreement
12:00am
8-K
bja auyoi
15 Jan 09
Oscient Pharmaceuticals and Ethypharm SA File Lawsuit Against Lupin for Infringement of ANTARA® Patent
12:00am
8-K
zjxn bhgrgc9tf3ze2fk
23 Dec 08
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
jncq2 qp45
16 Dec 08
Oscient Pharmaceuticals Announces Management Change
12:00am
8-K
96a7q6bmh
3 Dec 08
Oscient Pharmaceuticals Receives Paragraph IV
12:00am
8-K
9v3u0
28 Nov 08
Oscient Pharmaceuticals Announces Successful Completion of Convertible Debt Exchange Offer
12:00am
8-K
gvbuza6
20 Nov 08
Oscient Pharmaceuticals Announces Determination of the Consideration Issuable in its Exchange Offer
12:00am